Apellis Pharmaceuticals to Hold Fourth Quarter and Full Year 2020 Earnings Conference Call on February 25, 2021
Apellis Pharmaceuticals (APLS) announced it will hold a conference call on February 25, 2021, at 4:30 p.m. ET to discuss its fourth quarter and full year 2020 financial results. Interested participants can join the call by dialing (866) 774-0323 for domestic access or (602) 563-8683 for international access, using conference ID # 6956712. A webcast of the event will also be accessible via the company’s website, where a replay will be available for 90 days.
Apellis focuses on developing targeted C3 therapies for various diseases.
- Conference call scheduled for February 25, 2021, may indicate strong financial performance expectations.
- Focus on developing targeted C3 therapies highlights innovative approach within biopharmaceuticals.
- None.
WALTHAM, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2020 financial results on Thursday, February 25, 2021 at 4:30 p.m. ET.
The event will be available live by dialing (866) 774-0323 (Domestic) or (602) 563-8683 (International) and entering the conference ID # 6956712 or via webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.
About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.
Investor Contact:
Argot Partners
apellis@argotpartners.com
+1 212.600.1902
FAQ
When is Apellis Pharmaceuticals' financial conference call scheduled?
How can I access the Apellis Pharmaceuticals financial results call?
What does Apellis Pharmaceuticals specialize in?
Is there a replay available for the financial results call?
